Article Cited by others

COMMENTARY

What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials

Kaur Rimplejeet, Sidhu Preeti, Singh Surjit

Year : 2016| Volume: 7| Issue : 3 | Page no: 120-126

   This article has been cited by
 
1 Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek,Barbara Malinowska
Life Sciences. 2018; 204: 20
[Pubmed]  [Google Scholar] [DOI]
2 Drug conjugates-an emerging approach to treat breast cancer
Mahmud Hasan,Rehana K. Leak,Robert E. Stratford,Darius P. Zlotos,Paula A. Witt-Enderby
Pharmacology Research & Perspectives. 2018; 6(4): e00417
[Pubmed]  [Google Scholar] [DOI]
3 Characterization of fatty acid amide hydrolase activity by a fluorescence-based assay
Florian M. Dato,Andreas Maaßen,Bernd Goldfuß,Markus Pietsch
Analytical Biochemistry. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Carolyn Brokowski,Mazhar Adli
Journal of Molecular Biology. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl,Martin Storr,Rudolf Schicho
Expert Review of Gastroenterology & Hepatology. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
6 Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinsonæs disease
Noemi Pasquarelli,Christoph Porazik,Hanna Bayer,Eva Buck,Stefan Schildknecht,Patrick Weydt,Anke Witting,Boris Ferger
Neurochemistry International. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 The cannabinoid system and pain
Stephen G. Woodhams,Victoria Chapman,David P. Finn,Andrea G. Hohmann,Volker Neugebauer
Neuropharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article